Drippy: A New Cannabis Beverage Company Leverages Cutting-Edge AI Packaging on New “Deep End” 100mg THC-Infused Drink Launch
Los Angeles, California–(Newsfile Corp. – March 9, 2023) – Drippy Enterprises Inc. (“Drippy” or the…
Los Angeles, California–(Newsfile Corp. – March 9, 2023) – Drippy Enterprises Inc. (“Drippy” or the…
Washington, D.C., Mar 10, 2023 – (ACN Newswire) – The Government Blockchain Association (GBA) announces…
HONG KONG, Mar 10, 2023 – (ACN Newswire) – Yuexiu Real Estate Investment Trust (“Yuexiu…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
SAN FRANCISCO–(BUSINESS WIRE)–LinkLive, a leading cloud-based Contact Center as a Service (CCaaS) provider, has partnered…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
NAMUR, Belgium–(BUSINESS WIRE)–Sunrise, the company revolutionising home sleep testing, announces a €17 million in funding….
RIVERWOODS, Ill.–(BUSINESS WIRE)–Discover Financial Services (NYSE: DFS) today announced that Jason Hanson will succeed…
Affirmative vote required on March 30, 2023 special meeting of stockholders in order for the…
Experience leaders from world’s top brands – including Disney, Chipotle, and Delta – are using…
LOS ANGELES–(BUSINESS WIRE)–Guess?, Inc. (NYSE: GES) announced today that the Company will be participating in…
LA JOLLA, Calif., March 09, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
MISSISSAUGA, Ontario, March 09, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…
Atlas Global Brands today announced that it has completed most of its key integration activities…
WOODCLIFF LAKE, N.J., March 09, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
– On Track to Provide Initial Clinical Data from Gene Editing Trial for PKU Mid-Year with…
— Preliminary data from GRANITE Phase 2/3 study (individualized vaccine for first-line microsatellite-stable colorectal cancer…
NEWARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
– Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2…